A PYMNTS Company

Thirty-three states settle with Aventis and Ferring for delayed generic

 |  January 31, 2012

Thirty-three states have reached a settlement with Aventis and Ferring, two pharmaceutical companies, for delaying the entry of the generic for DDAVP (desmopressin). Barr Laboratories, the manufacturer of the generic, allegedly had its sales delayed because of materially misleading statements Aventis and Ferring made to the U.S. Patent Office.

Source: LegalNewsline


Related content: Whistling Past the Graveyard: The Problem with the Per Se Legality Treatment of Pay-For-Delay Settlements (Michael Kades, U.S. Federal Trade Commission)